KRAS Mutations Predict Inferior Post-Remission Outcomes in Newly Diagnosed Acute Myeloid Leukemia With MAPK Pathway Mutations
{{output}}
Somatic mutations in the MAPK signaling pathway are frequently identified at AML diagnosis; however, their impact on treatment resistance and long-term survival remains unclear. We conducted a retrospective study of patients with newly diagnosed MAPK-mutated A... ...
